ArticleTherapeutics and clinical risk management2011

Critical appraisal of pralatrexate in the management of difficult-to-treat peripheral T cell lymphoma.

M Casanova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.